NCT03218761View on ClinicalTrials.gov

POTS NET mRNA Functional Correlation With NET Activity

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 14, 2017

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Postural Tachycardia Syndrome
Interventions
DIAGNOSTIC_TEST

NET mRNA level

quantification of mRNA to the Norepinephrine Transporter (NET)

DIAGNOSTIC_TEST

Plasma catechols

plasma for assay of norepinephrine (NE), DHPG (intraneuronal metabolite of NE), and other catechols

DIAGNOSTIC_TEST

Urine Catechols

urine for assay of norepinephrine (NE), DHPG (intraneuronal metabolite of NE), and other catechols

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

Sponsors
All Listed Sponsors
collaborator

University of Calgary

OTHER

collaborator

Dysautonomia International

OTHER

lead

Vanderbilt University Medical Center

OTHER

NCT03218761 - POTS NET mRNA Functional Correlation With NET Activity | Biotech Hunter | Biotech Hunter